Frontal and rostral anterior cingulate (rACC) theta EEG in depression: Implications for treatment outcome?

European Neuropsychopharmacology

Volumn 25, Issue 8, 2015, Pages 1190-1200

  Arns, Martijn ^a,b   Etkin, Amit ^c,d   Hegerl, Ulrich ^e   Williams, Leanne M ^c,d   DeBattista, Charles ^d   Palmer, Donna M ^f,g,h   Fitzgerald, Paul B ⁱ   Harris, Anthony ^h   deBeuss, Roger ^j   Gordon, Evian ^f,g  

^a UTRECHT UNIVERSITY   (Netherlands)

^b RESEARCH INSTITUTE BRAINCLINICS   (Netherlands)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f Brain Resource Ltd   (Australia)

^g Brain Resource International Database   (United States)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ Australia   (Australia)

^j UNIVERSITY OF NORTH CAROLINA AT ASHEVILLE   (United States)

more..

Author keywords

Anterior cingulate; Depression; EEG; LORETA; QEEG; Theta

Indexed keywords

ESCITALOPRAM; SERTRALINE; VENLAFAXINE; ANTIDEPRESSANT AGENT; CITALOPRAM;

ADULT; ANTERIOR CINGULATE; ARTICLE; CONTROLLED STUDY; DSM-IV; FEMALE; FRONTAL CORTEX; HAMILTON DEPRESSION RATING SCALE; HUMAN; INFERIOR FRONTAL GYRUS; LOW RESOLUTION BRAIN ELECTROMAGNETIC TOMOGRAPHY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE FRONTAL GYRUS; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; ROSTRAL ANTERIOR CINGULATE; SINGLE BLIND PROCEDURE; THETA RHYTHM; TREATMENT OUTCOME; TREATMENT RESPONSE; BRAIN MAPPING; CINGULATE GYRUS; CLINICAL TRIAL; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; FRONTAL LOBE; PATHOPHYSIOLOGY; PHASE 4 CLINICAL TRIAL; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN MAPPING; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SERTRALINE; SEVERITY OF ILLNESS INDEX; THETA RHYTHM; VENLAFAXINE HYDROCHLORIDE;

EID: 84938745204     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.03.007     Document Type: Article

References (46)

1. Arns, M., Bruder, G., Hegerl, U., Spooner, C., Palmer, D., Etkin, A.,... Gordon, E., (2015). EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study. Clinical Neurophysiology (in preparation).
2. Arns M., Kenemans J.L. Neurofeedback in ADHD and insomnia: vigilance stabilization through sleep spindles and circadian networks. Neurosci. Biobehav. Rev. 2012, 10.1016/j.neubiorev.2012.10.006.
3. Arns M., Drinkenburg P., Fitzgerald P., Kenemans L. Neurophysiological predictors of non-response to rTMS in depression. Brain Stimul. 2012, 5:569-576. 10.1016/j.brs.2011.12.003.
4. Arns M., Gunkelman J., Breteler M., Spronk D. EEG phenotypes predict treatment outcome to stimulants in children with ADHD. J. Integr. Neurosci. 2008, 7(3):421-438.
5. Asada H., Fukuda Y., Tsunoda S., Yamaguchi M., Tonoike M. Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neurosci. Lett. 1999, 274(1):29-32.
6. Brody A.L., Saxena S., Silverman D.H., Alborzian S., Fairbanks L.A., Phelps M.E., Baxter L.R. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 1999, 91(3):127-139.
7. Cook I.A., Leuchter A.F., Witte E., Abrams M., Uijtdehaage S.H., Stubbeman W., Dunkin J.J. Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Res. 1999, 85(3):263-273.
8. Dougherty D.D., Weiss A.P., Cosgrove G.R., Alpert N.M., Cassem E.H., Nierenberg A.A., Rauch S.L. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J. Neurosurg. 2003, 99(6):1010-1017. 10.3171/jns.2003.99.6.1010.
9. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr. Clin. Neurophysiol. 1983, 55(4):468-484.
10. Hasler G., Northoff G. Discovering imaging endophenotypes for major depression. Mol. Psychiatry 2011, 16(6):604-619. 10.1038/mp.2011.23.
11. Hunter A.M., Korb A.S., Cook I.A., Leuchter A.F. Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication?. J. Neuropsychiatr. Clin. Neurosci. 2013, 25(2):126-133. 10.1176/appi.neuropsych.11110330.
12. Iosifescu D.V., Greenwald S., Devlin P., Mischoulon D., Denninger J.W., Alpert J.E., Fava M. Frontal EEG predictors of treatment outcome in major depressive disorder. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 2009, 19(11):772-777. 10.1016/j.euroneuro.2009.06.001.
13. Ishii R., Shinosaki K., Ukai S., Inouye T., Ishihara T., Yoshimine T., Takeda M. Medial prefrontal cortex generates frontal midline theta rhythm. Neuroreport 1999, 10(4):675-679.
14. Jaworska N., Blier P., Fusee W., Knott V. Α power, α asymmetry and anterior cingulate cortex activity in depressed males and females. J. Psychiatr. Res. 2012, 46(11):1483-1491. 10.1016/j.jpsychires.2012.08.003.
15. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J., Johnson B.T. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med. 2008, 5(2):e45. 10.1371/journal.pmed.0050045.
16. Knott V.J., Telner J.I., Lapierre Y.D., Browne M., Horn E.R. Quantitative EEG in the prediction of antidepressant response to imipramine. J. Affect. Disord. 1996, 39(3):175-184.
17. Knott V., Mahoney C., Kennedy S., Evans K. Pre-treatment EEG and it's relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry 2000, 33(6):201-205.
18. Konarski J.Z., Kennedy S.H., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S., Mayberg H.S. Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J. Psychiatry Neurosci. 2009, 34(3):175-180.
19. Korb A.S., Cook I.A., Hunter A.M., Leuchter A.F. Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr. 2008, 21(2):138-146. 10.1007/s10548-008-0070-5.
20. Korb A.S., Hunter A.M., Cook I.A., Leuchter A.F. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin. Neurophysiol.: Off. J. Int. Fed. Clin. Neurophysiol. 2009, 120(7):1313-1319. 10.1016/j.clinph.2009.05.008.
21. Li C.T., Hsieh J.C., Huang H.H., Chen M.H., Juan C.H., Tu P.C., Su T.P. Cognition-modulated frontal activity in prediction and augmentation of antidepressant efficacy: a randomized controlled pilot study. Cereb. Cortex 2014, 10.1093/cercor/bhu191.
22. Lubar J.F., Congedo M., Askew J.H. Low-resolution electromagnetic tomography (LORETA) of cerebral activity in chronic depressive disorder. Int. J. Psychophysiol.: Off. J. Int. Organ. Psychophysiol. 2003, 49(3):175-185.
23. Maurer U., Brem S., Liechti M., Maurizio S., Michels L., Brandeis D. Frontal midline theta reflects individual task performance in a working memory task. Brain Topogr. 2014, 10.1007/s10548-014-0361-y.
24. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Kennedy S.H. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45(5):651-660. 10.1016/j.neuron.2005.02.014.
25. McCormick L.M., Boles Ponto L.L., Pierson R.K., Johnson H.J., Magnotta V., Brumm M.C. Metabolic correlates of antidepressant and antipsychotic response in patients with psychotic depression undergoing electroconvulsive therapy. J. Electroconvuls. Ther. 2007, 23(4):265-273. 10.1097/yct.0b013e318150d56d.
26. Mientus S., Gallinat J., Wuebben Y., Pascual-Marqui R.D., Mulert C., Frick K., Winterer G. Cortical hypoactivation during resting EEG in schizophrenics but not in depressives and schizotypal subjects as revealed by low resolution electromagnetic tomography (LORETA). Psychiatry Res.: Neuroimaging 2002, 116(1-2):95-111.
27. Mottaghy F.M., Keller C.E., Gangitano M., Ly J., Thall M., Parker J.A., Pascual-Leone A. Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res. 2002, 115(1-2):1-14.
28. Mulert C., Juckel G., Brunnmeier M., Karch S., Leicht G., Mergl R., Pogarell O. Prediction of treatment response in major depression: integration of concepts. J. Affect. Disord. 2007, 98(3):215-225. 10.1016/j.jad.2006.07.021.
29. Mulert C., Juckel G., Brunnmeier M., Karch S., Leicht G., Mergl R., Pogarell O. Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication. Clin. EEG and Neurosci.: Off. J. EEG and Clin. Neurosci. Soc. 2007, 38(2):78-81. 10.1177/155005940703800209.
30. Narushima K., McCormick L.M., Yamada T., Thatcher R.W., Robinson R.G. Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression. J. Neuropsychiatry Clin. Neurosci. 2010, 22(1):75-84. 10.1176/appi.neuropsych.22.1.75.
31. Olbrich S., Arns M. EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response. Int. Rev. Psychiatry 2013, 25(5):604-618. 10.3109/09540261.2013.816269.
32. Pascual-Marqui R.D. Standardized low-resolution brain electromagnetic tomography (sloreta): technical details. Methods Find. Exp. Clin. Pharmacol. 2002, 24(Suppl. D):S5-S12.
33. Pascual-Marqui, R.D. 2007. Discrete, 3D distributed, linear imaging methods of electric neuronal activity. Part 1: exact, zero error localization. ArXiv Preprint ArXiv:0710.3341.
34. Pascual-Marqui R.D., Michel C.M., Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int. J. Psychophysiol.: Off. J. Int. Organ. Psychophysiol. 1994, 18(1):49-65.
35. Paul R.H., Gunstad J., Cooper N., Williams L.M., Clark C.R., Cohen R.A., Gordon E. Cross-cultural assessment of neuropsychological performance and electrical brain function measures: additional validation of an international brain database. Int. J. Neurosci. 2007, 117(4):549-568. 10.1080/00207450600773665.
36. Pizzagalli D., Pascual-Marqui R.D., Nitschke J.B., Oakes T.R., Larson C.L., Abercrombie H.C., Davidson R.J. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am. J. Psychiatry 2001, 158(3):405-415.
37. Pizzagalli D.A. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2011, 36:183-206.
38. Pizzagalli D.A., Nitschke J.B., Oakes T.R., Hendrick A.M., Horras K.A., Larson C.L., Davidson R.J. Brain electrical tomography in depression: the importance of symptom severity, anxiety, and melancholic features. Biol. Psychiatry 2002, 52(2):73-85.
39. Rentzsch J., Adli M., Wiethoff K., Gómez-Carrillo de Castro A., Gallinat J. Pretreatment anterior cingulate activity predicts antidepressant treatment response in major depressive episodes. Eur. Arch. Psychiatry Clin. Neurosci 2013, 10.1007/s00406-013-0424-1.
40. Saveanu R., Etkin A., Duchemin A.M., Goldstein-Piekarski A., Gyurak A., Debattista C., Williams L.M. The international study to predict optimized treatment in depression (ispot-d): outcomes from the acute phase of antidepressant treatment. J. Psychiatr. Res. 2014, 10.1016/j.jpsychires.2014.12.018.
41. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Dunbar G.C. The mini-international neuropsychiatric interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59:22-33.
42. Spronk D., Arns M., Barnett K., Cooper N., Gordon E. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study. J. Affect. Disord. 2011, 128:41-48.
43. van Beijsterveldt C.E., Molenaar P.C., de Geus E.J., Boomsma D.I. Heritability of human brain functioning as assessed by electroencephalography. Am. J. Hum. Genet. 1996, 58(3):562-573.
44. Walter W., Dovey V.J. Electro-encephalography in cases of sub-cortical tumour. J. Neurol. Neurosurg. Psychiatry 1944, 7(3-4):57. 10.1136/jnnp.7.3-4.57.
45. Williams L.M., Rush A.J., Koslow S.H., Wisniewski S.R., Cooper N.J., Nemeroff C.B., Gordon E. International study to predict optimized treatment for depression (ispot-d), a randomized clinical trial: rationale and protocol. Trials 2011, 12:4. 10.1186/1745-6215-12-4.
46. Williams L.M., Simms E., Clark C.R., Paul R.H., Rowe D., Gordon E. The test-retest reliability of a standardized neurocognitive and neurophysiological test battery: "neuromarker". Int. J. Neurosci. 2005, 115(12):1605-1630. 10.1080/00207450590958475.